In view of its less than flattering share price performance over the last few years and in particular in recent months since launching the bid ARQ could be in trouble here imo.
ACW This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game
History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025